Evidence map›Paper›PMID 26684814›Full record

ArticleClinical genitourinary cancer2016

Antitumor Response to Combined Antiangiogenic and Cytotoxic Chemotherapy in Recurrent Metastatic Chromophobe Renal Cell Carcinoma: Response Signatures and Proteomic Correlates.

Abhishek Maiti, Robert E Brown, Paul G Corn, Ravi Murthy, Dhakshina Moorthy Ganeshan, Apostolia M Tsimberidou, Vivek Subbiah

Open access · greenAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical genitourinary cancer, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Abhishek MaitiDepartment of Internal Medicine, University of Texas Health Sciences Center at Houston, Houston, TX.
Robert E BrownDepartment of Pathology and Laboratory Medicine, University of Texas Health Sciences Center at Houston, Houston, TX.
Paul G CornDivision of Cancer Medicine, Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Ravi MurthyDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Dhakshina Moorthy GaneshanDepartment of Diagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX.
Apostolia M TsimberidouDivision of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Vivek SubbiahDivision of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: vsubbiah@mdanderson.org.
The University of Texas MD Anderson Cancer Center · USThe University of Texas Health Science Center at Houston · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Kathrin Milbury · 1985 to 2026
$290.8M
NCI NIH HHS CA016672NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antineoplastic Combined Chemotherapy ProtocolsBevacizumabCapecitabineCarcinoma, Renal CellHumansKidney NeoplasmsMaleMechanistic Target of Rapamycin Complex 2Middle AgedMultiprotein ComplexesNeoplasm MetastasisOrganoplatinum CompoundsOxaliplatinProteomicsSequence Analysis, DNASignal TransductionBevacizumabCapecitabineMechanistic Target of Rapamycin Complex 2Multiprotein ComplexesOrganoplatinum CompoundsOxaliplatinTOR Serine-Threonine KinasesCell signaling pathwaysMorphoproteomicsRefractoryResistanceResistant

Identifiers

PMID26684814
PMCPMC4783251
OpenAlexW2219090871

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.